On the other hand, simultaneous mutations in the Catnb (β-catenin) and Hras genes by using the same technology cooperatively accelerated HCC development (Table 5), as β-catenin may promote the clonal expansion of Hras-induced dysplastic (preneoplastic) cells [208]. The gene discussed is HRAS; the disease is hepatocellular carcinoma.